Our approach

How We Turn Uncertainty into Decisions

At Esylos, every engagement starts from the same place: the drug development strategy decision that needs to be made, and what it will take to make it with confidence in the face of uncertainty.

We partner with your team to enable informed decision-making when the path forward is unclear, data is incomplete, and the cost of being wrong is high.

What Makes the Difference

Esylos operates above execution and across silos. Where a biostatistician delivers an analysis and a regulatory consultant drafts a submission, Esylos sits between science, data and strategy, responsible for how all of it connects into a coherent development path.

Traditional consultants deliver reports. CROs execute parts. Esylos carries the global development logic.


What Makes the Difference

Esylos operates above execution and across silos. Where a biostatistician delivers an analysis and a regulatory consultant drafts a submission, Esylos sits between science, data and strategy, responsible for how all of it connects into a coherent development path.

Traditional consultants deliver reports. CROs execute parts. Esylos carries the global development logic.


What Makes the Difference

Esylos operates above execution and across silos. Where a biostatistician delivers an analysis and a regulatory consultant drafts a submission, Esylos sits between science, data and strategy, responsible for how all of it connects into a coherent development path.

Traditional consultants deliver reports. CROs execute parts. Esylos carries the global development logic.


What This Looks Like in Practice

Imagine a rare disease biotech with three competing development paths and no clear way to choose. One path looks faster but riskier. Another has stronger data but faces a tougher regulatory route. The third requires a manufacturing decision that locks in cost commitments for years.

Most consultants would analyze each path in isolation. Esylos maps the full decision landscape — structuring what the team already knows, quantifying the uncertainty around each option, simulating downstream consequences, and delivering a clear recommendation that accounts for the interconnections between clinical, manufacturing, and regulatory strategy.

That’s the difference between delivering an analysis and carrying the development logic.


What This Looks Like in Practice

Imagine a rare disease biotech with three competing development paths and no clear way to choose. One path looks faster but riskier. Another has stronger data but faces a tougher regulatory route. The third requires a manufacturing decision that locks in cost commitments for years.

Most consultants would analyze each path in isolation. Esylos maps the full decision landscape — structuring what the team already knows, quantifying the uncertainty around each option, simulating downstream consequences, and delivering a clear recommendation that accounts for the interconnections between clinical, manufacturing, and regulatory strategy.

That’s the difference between delivering an analysis and carrying the development logic.


What This Looks Like in Practice

Imagine a rare disease biotech with three competing development paths and no clear way to choose. One path looks faster but riskier. Another has stronger data but faces a tougher regulatory route. The third requires a manufacturing decision that locks in cost commitments for years.

Most consultants would analyze each path in isolation. Esylos maps the full decision landscape — structuring what the team already knows, quantifying the uncertainty around each option, simulating downstream consequences, and delivering a clear recommendation that accounts for the interconnections between clinical, manufacturing, and regulatory strategy.

That’s the difference between delivering an analysis and carrying the development logic.


Methods Built for
Real Decisions

Every method we use is connected to a concrete decision you need to make. We group our methodological toolkit into four clusters:

[01]

Knowledge & Structure

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Causal and knowledge graphs

map the structure of your program to understand what drives outcomes and where intervention points lie

Knowledge elicitation with Bayesian networks

structure expert judgment into probabilistic models that integrate with emerging data

Causal discovery

identify hidden relationships in complex datasets to uncover mechanisms that drive efficacy and safety

[02]

Evidence & Inference

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Causal inference and target trial emulation

extract causal evidence from observational data when randomized trials are not feasible or ethical

Omics and biomarker identification

leverage genomic, proteomic, and metabolomic data to identify patient populations and predict response

Real-world evidence

extract signal from registries, claims data, and population studies to strengthen development strategy

[03]

Simulation & Design

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Digital twins

simulate your development program computationally to test decisions before making them in the real world

Design of innovative clinical trials

Bayesian adaptive designs, platform trials, and novel endpoints

Quality by Design

align manufacturing and quality decisions with clinical and regulatory strategy from the start

[04]

Intelligence & Automation

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Agentic AI

intelligent systems that continuously monitor program health and surface decision points before they become bottlenecks

Automation of manufacturing processes

intelligent process controls that reduce variability, improve yield, and create defensible CMC documentation

[01]

Knowledge & Structure

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Causal and knowledge graphs

map the structure of your program to understand what drives outcomes and where intervention points lie

Knowledge elicitation with Bayesian networks

structure expert judgment into probabilistic models that integrate with emerging data

Causal discovery

identify hidden relationships in complex datasets to uncover mechanisms that drive efficacy and safety

[02]

Evidence & Inference

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Causal inference and target trial emulation

extract causal evidence from observational data when randomized trials are not feasible or ethical

Omics and biomarker identification

leverage genomic, proteomic, and metabolomic data to identify patient populations and predict response

Real-world evidence

extract signal from registries, claims data, and population studies to strengthen development strategy

[03]

Simulation & Design

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Digital twins

simulate your development program computationally to test decisions before making them in the real world

Design of innovative clinical trials

Bayesian adaptive designs, platform trials, and novel endpoints

Quality by Design

align manufacturing and quality decisions with clinical and regulatory strategy from the start

[04]

Intelligence & Automation

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Agentic AI

intelligent systems that continuously monitor program health and surface decision points before they become bottlenecks

Automation of manufacturing processes

intelligent process controls that reduce variability, improve yield, and create defensible CMC documentation

Homepage

Approach

Services

Our vision

Contact

How can we help you achieve your goals?

Describe your challenges

group of people using laptop computer

How can we help you achieve your goals?

Describe your challenges

group of people using laptop computer

How can we help you achieve your goals?

Describe your challenges

group of people using laptop computer

Homepage

Approach

Services

Our vision

Contact us

Terms & conditions

Privacy policy

Homepage

Approach

Services

Our vision

Contact us

Terms & conditions

Privacy policy

Homepage

Approach

Services

Our vision

Contact us

Terms & conditions

Privacy policy

Homepage

Approach

Services

Our vision

Contact

Homepage

Approach

Services

Our vision

Contact

Create a free website with Framer, the website builder loved by startups, designers and agencies.